ALOPECIA and Potassium

PatientsVille

Find and Compare Side Effects

ALOPECIA Symptoms and Causes

You lose up to 100 hairs from your scalp every day. That's normal, and in most people, those hairs grow back. But many men -- and some women -- lose hair as they grow older. You can also lose your hair if you have certain diseases, such as thyroid problems, diabetes, or lupus. If you take certain medicines or have chemotherapy for cancer, you may also lose your hair. Other causes are stress, a low protein diet, a family history, or poor nutrition.

Treatment for hair loss depends on the cause. In some cases, treating the underlying cause will correct the problem. Other treatments include medicines and hair restoration.

ALOPECIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.

The goal of this study is to assess the feasibility, safety and response to treatment of the use of the 308-nm excimer laser in children diagnosed with patch type Alopecia areata involving the scalp, present for more than 6 months duration; Evaluate the feasibility and safety of twice-weekly excimer laser treatments over a period of 12 weeks

Change in the percentage of hair regrowth for each half. We will consider the treamtment successful if there was ≥50% hair regrowth from baseline.; Change in hair count and caliber in each half; Assessment of side effects in each half

Proportion of subjects with a change in sexual function defined as a negative change from baseline in the IIEF-EF score of >=4 units or a score of <=25 on or before Week 24; Proportion of subjects with a negative change from baseline in the IIEF-EF score of >=4 units or a score of <=25 on or before Weeks 4 and 12 as well as the Follow-up Visit; Change from baseline in total score of the IIEF at Weeks 4, 12, and 24 as well as the Follow-up Visit; Change from baseline in the individual domain scores: erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall sexual satisfaction, of the IIEF at Weeks 4, 12 and 24 as well as the Follow-up Visit; Change from baseline in subject satisfaction with hair growth as assessed by the total score of the Hair Growth Satisfaction Scale (HGSS) at Weeks 12 and 24; Change from baseline in the total score of the Dermatology Life Quality Index (DLQI) at Weeks 12 and 24; Occurrence of adverse events related to sexual dysfunction

If you think you may have a medical emergency, call your doctor or 911 immediately.

By accessing this website, you are indicating your acknowledgement and acceptance of these Terms of Use. These Terms of Use are subject to change by WinFirst LLC at any time in its discretion. Your use of WinFirst LLC Site after such changes are implemented constitutes your acknowledgement and acceptance of the changes. Please consult these Terms of Use regularly.
PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.